cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Finch Therapeutics Group Inc
11 own
16 watching
Current Price
$2.35
$-0.17
(-6.75%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
6.16M
52-Week High
52-Week High
16.74000
52-Week Low
52-Week Low
1.86000
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization6.16M
icon52-Week High16.74000
icon52-Week Low1.86000
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio--
What does the Finch Therapeutics Group Inc do?
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company s lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.
Read More
How much money does Finch Therapeutics Group Inc make?
News & Events about Finch Therapeutics Group Inc.
PR Newswire
10 months ago
Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics? Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics? PR Newswire NEW YORK, June 13, 2023 NEW YORK, June 13, 2023 /PRNewswire/ -- InvestorsObserver issues...
Globe Newswire
10 months ago
BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Finch, Finch Therapeutics or the Company) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced it will effect a one-for-30 reverse stock split of its ...
Zolmax
1 year ago
Atara Biotherapeutics (NASDAQ:ATRA Get Rating) and Finch Therapeutics Group (NASDAQ:FNCH Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, ...
Globe Newswire
1 year ago
SOMERVILLE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (the Company, Finch, or Finch Therapeutics) (Nasdaq: FNCH) today announced its decision to discontinue the PRISM4 Phase 3 trial of CP101 in recurrent C. difficile infection (CDI) and focus on realizing the value of ...
Globe Newswire
1 year ago
SOMERVILLE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Finch or Finch Therapeutics) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs, today ...
Frequently Asked Questions
Frequently Asked Questions
What is Finch Therapeutics Group Inc share price today?
plus_minus_icon
Can Indians buy Finch Therapeutics Group Inc shares?
plus_minus_icon
How can I buy Finch Therapeutics Group Inc shares from India?
plus_minus_icon
Can Fractional shares of Finch Therapeutics Group Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Finch Therapeutics Group Inc stocks?
plus_minus_icon
What is today’s traded volume of Finch Therapeutics Group Inc?
plus_minus_icon
What is today’s market capitalisation of Finch Therapeutics Group Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Finch Therapeutics Group Inc?
plus_minus_icon
What percentage is Finch Therapeutics Group Inc down from its 52-Week High?
plus_minus_icon
What percentage is Finch Therapeutics Group Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.35
$-0.17
(-6.75%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00